Skip to content
Disclosery

EXANE DERIVATIVES: TIP position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on TIP, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 4 TIP shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 4 shares
    Change vs previous 13F -6,068 shares

    <0.01% of the 13F portfolio, value $456.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 6,072 shares
    Change vs previous 13F +2,503 shares

    0.21% of the 13F portfolio, value $756,394.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 3,569 shares
    Change vs previous 13F +229 shares

    0.11% of the 13F portfolio, value $461,130.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 3,340 shares
    Change vs previous 13F -88 shares

    0.11% of the 13F portfolio, value $426,499.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 3,428 shares
    Change vs previous 13F +126 shares

    0.1% of the 13F portfolio, value $439,718.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 3,302 shares
    Change vs previous 13F +1,231 shares

    0.12% of the 13F portfolio, value $414,417.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 2,071 shares
    Change vs previous 13F -344 shares

    0.08% of the 13F portfolio, value $264,373.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 2,415 shares
    Change vs previous 13F not available

    0.1% of the 13F portfolio, value $305,502.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).